|
|
|
Insider
Information: |
Nea 15 Gp, Llc |
Relationship: |
10% Owner |
City: |
Timonium |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
10,554,932 |
|
Indirect Shares
|
53,202,139 |
|
|
Direct
Value |
$130,378 |
|
|
Indirect Value
|
$217,605,898 |
|
|
Total
Shares |
63,757,071 |
|
|
Total
Value |
$217,736,276 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
137.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvelo Inc |
ABIO |
10% Owner |
2018-02-26 |
0 |
|
0 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
2016-01-13 |
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
2022-10-19 |
0 |
2022-10-19 |
0 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2016-12-19 |
5,215,128 |
|
0 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
2018-03-09 |
0 |
2018-02-20 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
2,902,115 |
2020-07-14 |
0 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
2,437,689 |
2020-07-28 |
0 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2021-05-24 |
0 |
2021-05-24 |
4,520,019 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
2021-06-08 |
0 |
2021-06-08 |
19,263,413 |
Premium* |
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
3,494,244 |
Premium* |
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
0 |
2022-11-16 |
14,614,829 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
0 |
2022-12-20 |
4,745,262 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACLX |
Arcellx, Inc. |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
ACLX |
Arcellx, Inc. |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
0 |
0 |
- |
|
ABIO |
Nuvelo Inc |
10% Owner |
|
2018-02-26 |
4 |
S |
$0.50 |
$731,273 |
D/D |
(1,460,209) |
0 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
D/D |
1,818,000 |
10,882,574 |
0 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2018-05-25 |
4 |
A |
$4.00 |
$3,333,332 |
I/I |
833,333 |
3,082,186 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2020-06-19 |
4 |
B |
$5.25 |
$7,499,998 |
D/D |
1,428,571 |
3,952,958 |
2.45 |
% |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2019-12-09 |
4 |
A |
$6.25 |
$2,500,000 |
I/I |
400,000 |
3,482,186 |
0 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2016-07-18 |
4 |
B |
$8.73 |
$13,333,338 |
I/I |
1,527,301 |
2,665,519 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2016-01-13 |
4 |
B |
$10.00 |
$10,000,000 |
I/I |
1,000,000 |
1,901,869 |
1.5 |
- |
|
AKAO |
Achaogen Inc |
10% Owner |
|
2016-12-19 |
4 |
B |
$13.50 |
$6,750,000 |
D/D |
500,000 |
5,215,128 |
2.45 |
- |
|
INZY |
Inozyme Pharma, Inc. |
10% Owner |
|
2020-07-28 |
4 |
B |
$16.00 |
$4,000,000 |
D/D |
250,000 |
2,437,689 |
2.45 |
- |
|
NKTX |
Nkarta, Inc. |
10% Owner |
|
2020-07-14 |
4 |
B |
$18.00 |
$11,999,988 |
D/D |
666,666 |
2,902,115 |
2.45 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2020-10-20 |
4 |
B |
$18.00 |
$5,599,998 |
D/D |
311,111 |
6,520,017 |
2.45 |
- |
|
38 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|